• Skip to primary navigation
  • Skip to main content
English Spainish
My Account
LaRed Home

LaRed

Mexican Emerging Infectious Disease Clinical Research Network

  • About Us
    • About Us
    • Leadership
    • Partners
  • Studies
    • ACTT
    • CN-SARI
    • FLU-IVIG
    • FLU-PRO
    • HEALTHY COHORT
    • INSIGHT-011
    • ILI 2014
    • ILI 002
    • IRC 003
    • NTZ-SARI
    • SPRINT-SARI
    • ZIK 01
    • InVITE
    • OTAC
  • News and Events
  • Resources
    • Publications
    • Regulations / Policies
  • Contact Us
    • Contact Us
    • Sites

A unique immune signature of serum cytokine and chemokine dynamics in patients with Zika virus infection from a tropical region in Southern Mexico

May 14, 2020 by

https://www.redmexei.mx/storages/2020/05/Zuniga_et_al_2020_Intl-Journal-of-Infectious-Diseases.pdf

Comparison of Rates of Hospitalization Between Single and Dual Virus Detection in a Mexican Cohort of Children and Adults With Influenza-Like Illness

November 9, 2019 by

/wp-content/uploads/2019/11/Comparison-of-Rates-of-Hospitalization-Between-Single.pdf

Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City

October 4, 2019 by

/wp-content/uploads/2019/10/Clinical-characteristics-and-outcomes-of-influenza-and-other-influenza-like-illnesses-in-Mexico-City-.pdf

A Randomized Double-Blind Phase 2 Study of Combination Antivirals for the Treatment of Influenza

October 3, 2019 by

/wp-content/uploads/2019/10/A-Randomized-Double-Blind-Phase-2-Study-of-Combination-Antivirals-for-the-Treatment-of-Influenza.pdf

Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness

October 3, 2019 by

/wp-content/uploads/2019/10/Efficacy-and-Safety-of-Nitazoxanide-in-Addition-to-Standard-of-Care-for-the-Treatment-of-Severe-Acute-Respiratory-Illness.pdf

Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome

October 3, 2019 by

/wp-content/uploads/2019/10/Differential-human-antibody-repertoires-following-Zika-infection-and-the-implications-for-serodiagnostics-and-disease-outcome.pdf

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Go to Next Page »
Footer Logo

The Mexican Emerging Infectious Disease Clinical Research Network (LaRed)

Address:
Coscomate 71, Int. 1A, Colonia Toriello Guerra, Alcaldía Tlalpan, CP 14050 CdMx
Phone:
(+52) 55 5573 0734, (+52) 55 5162 5552

Main Navigation


  • Home
  • About
  • Studies
  • News & Events
  • Resources
  • Contact

Site Help


  • Sitemap
  • Privacy
  • Terms Of Use
Copyright ©2019 All rights reserved | LaRed

Multilingual WordPress with WPML